pargyline has been researched along with Schizophrenia in 10 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Schizophrenia: A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SAUNDERS, JC | 2 |
| SHARPLEY, P | 1 |
| MENA, A | 1 |
| SCHIELE, BC | 1 |
| HEISTAD, G | 1 |
| TURNER, WJ | 1 |
| MERLIS, S | 1 |
| Karoum, F | 1 |
| Potkin, S | 1 |
| Chuang, LW | 1 |
| Murphy, DL | 2 |
| Liebowitz, MR | 1 |
| Wyatt, RJ | 1 |
| Donnelly, CH | 1 |
| Price, J | 1 |
| Hopkinson, G | 1 |
| Stein, L | 1 |
| Matussek, N | 1 |
| Bucci, L | 1 |
| Barsa, JA | 1 |
3 reviews available for pargyline and Schizophrenia
| Article | Year |
|---|---|
Monoamine oxidase in man: enzyme characteristics in platelets, plasma, and other human tissues.
Topics: Age Factors; Benzyl Compounds; Bipolar Disorder; Blood Platelets; Brain; Cyanides; Diseases in Twins | 1974 |
Mono-amine oxidase inhibitors and schizophrenia.
Topics: Acute Disease; Amines; Amphetamine; Chronic Disease; Hallucinogens; Humans; Iproniazid; Isoniazid; M | 1968 |
Neurochemistry of reward and punishment: some implications for the etiology of schizophrenia.
Topics: Animals; Ascorbic Acid; Bipolar Disorder; Brain; Dopamine; Feeding Behavior; Humans; Hypothalamus; M | 1971 |
1 trial available for pargyline and Schizophrenia
| Article | Year |
|---|---|
Clinical and animal experiments concerning the function of brain catecholamines.
Topics: Animals; Antidepressive Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Benserazide; Brain; Ca | 1971 |
6 other studies available for pargyline and Schizophrenia
| Article | Year |
|---|---|
Treatment of hospitalized depressed and schizophrenic patients with monoamine oxidase inhibitors: including reflections on pargyline.
Topics: Humans; Mental Disorders; Monoamine Oxidase Inhibitors; Pargyline; Schizophrenia | 1963 |
A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
Topics: Biomedical Research; Brain; Brain Damage, Chronic; Depressive Disorder, Major; Double-Blind Method; | 1964 |
A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS.
Topics: Adolescent; Biomedical Research; Brain; Brain Damage, Chronic; Depression; Depressive Disorder, Majo | 1964 |
Phenylacetic acid excretion in schizophrenia and depression: the origins of PAA in man.
Topics: Carbidopa; Chronic Disease; Clorgyline; Depressive Disorder; Female; Humans; Male; Pargyline; Phenet | 1984 |
The mono-amine oxidase inhibitors; their usefulness and their safety.
Topics: Adolescent; Adult; Chlorpromazine; Drug Synergism; Female; Humans; Middle Aged; Monoamine Oxidase In | 1969 |
A comparative study of tranylcypromine and paragyline.
Topics: Adolescent; Adult; Aged; Blood Pressure; Chlorpromazine; Chlorprothixene; Female; Humans; Methotrime | 1964 |